Precision BioSciences Inc (NAS:DTIL)
$ 10.37 -0.01 (-0.1%) Market Cap: 75.01 Mil Enterprise Value: -16.81 Mil PE Ratio: 33.87 PB Ratio: 1.00 GF Score: 59/100

Precision BioSciences Inc Interim Data Results for PBCAR0191- Conference Call Transcript

Dec 04, 2020 / 01:00PM GMT
Release Date Price: $249.15 (-18.82%)
Operator

Ladies and gentlemen, thank you for standing by and welcome to the Precision BioSciences Reports Positive Interim Results from PBCAR0191 Phase 1/2a Trial Conference Call.

At this time, all participants are in a listen-only mode. After the speaker presentation, there will be a question and answer session. (Operator Instructions) Please be advised that today's conference may be recorded. If you require any further assistance, please star zero.

I would now like to hand the conference over to your speaker today, Alex Kelly, please go ahead, sir.

Alex Kelly
Precision BioSciences - Chief Corporate Affairs Officer

Okay. Good morning everyone and welcome to our webcast to discuss the interim results for PBCAR0191 and relapsed and refractory NHL and BALL.

Before we begin, I would like to remind you that statements made during this webcast, that do not relate to matters of historical fact or like to future expectations in the lease, intentions goals, strategies, plans or prospects, our forward-looking statements within the meaning of the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot